Skip to main content

Table 2 Characteristics of those with TB-related death and non-TB-related death and controls

From: Tuberculosis mortality: patient characteristics and causes

  TB-related death (n = 43) Non-TB-related death (n = 206) Control (n = 498) p value
Age (years): mean 75 74 72 0.55
Male (%) 27 (62.8) 153 (74.3) 362 (72.7) 0.31
AFB smear-positive sputum (%) 12 (27.9) 49 (19.4) 99 (19.9) 0.43
Extrapulmonary involvement 25 (58.1) 41 (19.9) 132 (26.5) <0.001
 TB pleurisy or peritonitis 10 (23.3) 28 (13.6) 54 (10.8) 0.05
 TB lymphadenitis 0 1 (0.5) 6 (1.2) 0.54
 Urogenital TB 2 (4.7) 2 (1) 4 (0.8) 0.06
 Disseminated TB 13 (30.2) 5 (2.4) 34 (6.8) <0.001
  with meningitis 3 0 6  
  without meningitis 10 5 28  
 Gastrointestinal TB 0 3 (1.5) 2 (0.4) 0.25
 Musculoskeletal TB 0 2 (1) 26 (5.2) 0.01
 TB meningitis 0 0 6 (1.2) 0.22
Hemoglobin (g/dl): mean 10.6 11.7 11.4 0.001
Comorbidity (%) 23 (53.5) 162 (78.6) 184 (36.9) <0.001
 Malignancy 9 (20.9) 114 (55.3) 61 (12.2) <0.001
 Diabetes mellitus 10 (23.3) 55 (26.7) 117 (23.5) 0.66
 Liver cirrhosis 6 (14) 25 (12.1) 7 (1.4) <0.001
 Renal failure 4 (9.3) 24 (11.7) 15 (3.0) <0.001
HIV/AIDS (%) 2 (4.7) 2 (1.0) 9 (1.8) 0.24
MDRTB (%) 0 5 (2.4) 13 (2.6) 0.57
Radiographic pattern     
 Pneumonic patch 31 (72.1) 142 (68.9) 210 (42.2) <0.001
 Miliary shadow 4 (9.3) 6 (2.9) 24 (4.8) 0.17
 Cavity 4 (9.3) 9 (4.4) 58 (11.6) 0.01
 Other pattern 0 36 (17.5) 184 (36.9) <0.001
 No parenchymal lesion 4(9.3) 13 (6.3) 22 (4.4) 0.28
Delay in treatment >14 days 23 (53.5) 109 (52.9) 228 (45.8) 0.18
  1. AFB: acid-fast bacilli; HIV: human immunodeficiency virus; AIDS: acquired immunodeficiency syndrome; MDR: multidrug resistant; TB: tuberculosis.
  2. Data were percentages unless otherwise described.
  3. p-value for comparisons between mortality cases and survivors.